Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience

By Specchia G.   Pastore D.   Carluccio P.   Spinosa G.   Giannoccaro M.   Rizzi R.   Mestice A.   Liso V.  

Annals of Hematology, Vol. 86, Iss. 6, 2007-06 ,pp. : 425-428

Springer Publishing Company

Access to resources Recommend Favorite

Hemorrhagic cystitis in a patient receiving gemtuzumab ozogamicin for relapsed acute promyelocytic leukemia after cord blood transplantation

By Yoshimi Akihide  

Annals of Hematology, Vol. 87, Iss. 10, 2008-10 ,pp. : 851-852

Springer Publishing Company

Access to resources Recommend Favorite

FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance

By Grunwald Michael  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 683-694

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid

By Martini Vincenza   Minotti Clara   Breccia Massimo   Angelis Gioia   Buffolino Sonia   Mariella Montano   Lo-Coco Francesco   Avvisati Giuseppe   Cimino Giuseppe  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 295-297

Springer Publishing Company

Access to resources Recommend Favorite

Apoptosis and immaturity in acute myeloid leukemia

By Del Principe Maria Ilaria   Del Poeta Giovanni   Venditti Adriano   Buccisano Francesco   Maurillo Luca   Mazzone Carla   Bruno Antonio   Neri Benedetta   Irno Consalvo Maria   Lo Coco Francesco   Amadori Sergio  

Hematology, Vol. 10, Iss. 1, 2005-02 ,pp. : 25-34

Maney Publishing

Access to resources Recommend Favorite